Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2019-04-15 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
2018年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report' and includes detailed auditor opinions, audit basis, key audit matters, and extensive financial statements such as consolidated balance sheets, profit and loss statements, cash flow statements, and notes. It references the audit of the financial statements for the year ended December 31, 2018, and includes the auditor's signature and date. The content is consistent with a standalone audit report rather than a full annual report or other filing types. The length is substantial (15,000 characters), and it contains actual financial data and audit details, not just an announcement or certification. Therefore, the document fits the category of an Audit Report / Information (AR).
2019-04-15 Chinese
2019年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast (业绩预告) for the first quarter of 2019, indicating expected loss figures and basic earnings per share estimates. It explicitly states that the forecast is unaudited and preliminary, with final data to be confirmed in the official quarterly report. The document is short (663 characters) and serves as an announcement of expected financial results rather than a full financial report containing actual financial statements or detailed analysis. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results highlighting key figures and outlook. Q1 2019
2019-04-11 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a 2018 annual performance bulletin (业绩快报) for 江苏四环生物股份有限公司, containing preliminary financial data for the year 2018, including revenue, profit, net assets, and earnings per share. It explicitly states that the data are preliminary and may differ from the final annual report. The document is relatively short (1459 characters) and includes a note that the full annual report will be published later through official channels. This indicates that the document is a preliminary earnings release or performance bulletin rather than the full Annual Report (10-K). The content includes key financial highlights and explanations of performance changes, which aligns with the definition of an Earnings Release (ER). It is not a full Annual Report (10-K) because it lacks comprehensive financial statements and detailed disclosures. Therefore, the correct classification is Earnings Release (ER). FY 2018
2019-04-11 Chinese
关于股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations and related disclosures by the company. It includes explanations about the stock price movements, confirmation of no undisclosed material information, risk warnings, and references to regulatory investigations. It does not contain financial statements or detailed financial data but serves as a regulatory disclosure to inform investors and the market about the stock price anomaly and related compliance matters. The document length is short (1784 characters), and it is clearly an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements that do not fit other specific categories.
2019-04-11 Chinese
关于全资子公司完成工商变更登记事宜的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration changes for its wholly-owned subsidiaries. It details changes in business scope and legal representative for subsidiaries. There is no financial data, no mention of financial results, no regulatory certifications, no voting results, no legal proceedings, no capital changes, and no meeting materials. The document is a regulatory announcement about corporate administrative changes. It is short (867 characters) and does not contain or reference any report or financial statements. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2019-04-01 Chinese
关于立案调查事项进展暨风险提示的公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement from a company regarding the progress of an ongoing investigation by the China Securities Regulatory Commission (CSRC) into alleged violations. It includes risk warnings about potential stock suspension or delisting due to regulatory issues. The text does not contain financial statements, detailed financial data, or management discussion of results. It is a regulatory update about legal proceedings and compliance status. The document length is short (1143 characters), and it is clearly an announcement rather than a full report. Therefore, it fits best under the category of Legal Proceedings Report (LTR).
2019-03-24 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.